Navigation Links
MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
Date:4/22/2013

KENNESAW, Ga., April 22, 2013 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its common stock has been approved for listing on The NASDAQ Capital Market under the ticker symbol "MDXG."  Trading on NASDAQ is expected to commence on Thursday, April 25, 2013. Until such date, the Company's common stock will continue to be traded on OTC.BB under its current ticker symbol "MDXG".

"Listing on the NASDAQ exchange is an integral part of our plan to broaden and strengthen our shareholder base," said Parker H. "Pete" Petit, MiMedx Chairman and CEO.  "We expect the NASDAQ listing will increase the visibility of our stock, provide greater access to our stock and attract a broader range of investors to our stock, each of which is an essential element of our overall strategy to build shareholder value."

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary Purion® Process, to produce a safe, effective and minimally manipulated
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
2. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
3. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
4. MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts
5. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
6. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
7. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
8. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
9. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
10. MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
11. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... As part of its philanthropic partnership with Banner ... funded a $3.25 million project to relocate and equip ... up-to-date features and technology. , The new pharmacy is ... members will begin moving from the current location to ... , The current pharmacy has been using a ...
(Date:5/21/2015)... VANCOUVER , May 21, 2015 /PRNewswire/ - ... a clinical stage regenerative medicine company focused on ... an upcoming poster presentation at the International Society ... treatment for chronic Achilles tendinosis currently in a ... on May 29 th from 5:30 PM ...
(Date:5/21/2015)... May 21, 2015 Tunnell Consulting, ... the firm as senior statistician and Principal, a position ... experience in the management and analysis of complex and ... chemical industries. , “We’re delighted to have Julia join ... data analytics,” said Dr. Philippe Cini, Group Vice President ...
(Date:5/20/2015)... and Markets ( http://www.researchandmarkets.com/research/x4b7kw/top_technologies ) has announced ... Insights" report to their offering. Technical ... the Health and Wellness sector and has identified top ... in the year 2015. The research service provides an ... wellness technologies that are anticipated to have the highest ...
Breaking Biology Technology:Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 3RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Top Technologies in the Health and Wellness Industry 2015 2
... PharmAthene, Inc.,(Amex: PIP ) announced today that ... Chancery for 2:00 p.m. on Monday, August 27, 2007, ... pursuant to,Section 225(b) of the Delaware General Corporation Law ... the merger between,PharmAthene, Inc. and Healthcare Acquisition Corp. (the ...
... 17 Keck Graduate Institute,(KGI) today announced that ... for advancement following a national search. Howell, ... in fundraising,communications, marketing and business development working with ... thrilled to have someone of Kerry,s caliber and ...
... 17 /PRNewswire-FirstCall/ - YM BioSciences Inc.,(AMEX: YMI ... identifies, develops,and commercializes differentiated products for patients ... be disclosed in accordance with,Rule 26 of ... in the "Shareholder,Information/Rule 26 Disclosures" section on ...
Cached Biology Technology:Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp. 2Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp. 3Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp. 4KGI Names Kerry Howell Vice President for Advancement 2YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26 2
(Date:5/21/2015)... 2015 According to a ... (Hardware, Software, Services), by Applications (Surveillance (Airborne, Maritime, ... End-Users (Military & Defense & Commercial) - Global ... Market is expected to grow from $7252.0 Million ... a Compound Annual Growth Rate (CAGR) of 6.6%. ...
(Date:5/19/2015)... , May 19, 2015  Technology is rapidly advancing, ... and in the cloud. Passwords and their management are ... OTP and standards-based specifications such as those developed by ... use of passwords presents for BYOD, COPE, IoT, and ... biometric identity protocol. In response to ...
(Date:5/11/2015)... 11, 2015  Synaptics Incorporated (NASDAQ: SYNA ... today announced the appointment of Wajid Ali ... Officer, reporting to Rick Bergman , President ... Financial Officer, Kathleen Bayless , who announced ... Mr. Ali brings extensive financial management expertise to ...
Breaking Biology News(10 mins):Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... neuroscientists from The University of Nottingham and University of Birmingham ... thanks to new research using functional Magnetic Resonance Imaging (fMRI) ... map a kind of brain function that up to now ... how both healthy and diseased brains work. Functional ...
... have made a new step toward understanding whyand how ... (COPD) and allergic asthma. In a new report appearing ... FASEB Journal scientists show that two receptors ... roles in turning inflammation on and off for allergic ...
... theory on its head by giving selfish players a sure ... Michigan State University offer new evidence that the selfish will ... will punish you if you,re selfish and mean," said lead ... "For a short time and against a specific set of ...
Cached Biology News:A new tool for brain research 2Inflammatory on and off switch identified for allergic asthma and COPD 2Nice organisms finish first: Why cooperators always win in the long run 2Nice organisms finish first: Why cooperators always win in the long run 3
Human FGF R2 (alpha isoforms) MAb (Clone 98706)...
... Nucleon HT, 1 kit. Facilitates the simple, ... sections and hard tissue requiring proteinase K ... quality DNA from 50 preparations of up ... DNA/RNA Synthesis & Purification, Purification and Amplification ...
Request Info...
Ultra-sensitive, non-radioactive measurement of COX-I and COX-II activity...
Biology Products: